User:JZindler/sandbox-bob-bradway
Hi there! I have a COI: Amgen, Robert Bradway's employer, is a client of my employer, Porter Novelli. Requesting some edits to this article, which I've broken out by section below.
Career
- After "He and four other top Amgen executives earned a combined $124.2 million over a three-year period spanning 2017–2019.", add a new paragraph:
- During Bradway’s tenure as CEO, Amgen’s annual revenues have increased from $17.3 billion in 2012[1] to $25.4 billion in 2020 [2], and annual R&D investment increased to $4.2 billion in 2020[3]. Bradway oversaw the acquisition of Iceland-based DeCODE Genetics in 2012[4], Onyx Pharmaceuticals in 2013[5], and a 20.5% equity stake in Beijing-based BeiGene in 2020[6].
- Below career, add a new section titled "Speaking Engagements", and add the following text:
- Bradway was a keynote speaker at the World Medical Innovation Forum, held in Boston, Massachusetts in May 2015[7].
- In June 2017, Bradway gave the keynote address at the commencement ceremony for graduates of the University of California, Los Angeles (UCLA) Anderson School of Management[9].
- In January 2019, Bradway spoke with CNBC’s Jim Cramer about Amgen’s new migraine treatment, as well as the company’s decision to reduce the list price of Repatha by 60% in the U.S.[10].
- During a fireside chat with Fortune Editor-in-Chief Clifton Leaf at the magazine’s Brainstorm Health conference in July 2020, Bradway commented that “we’re witnessing fast progress” in clinical trials for a COVID-19 vaccine, and that he’s “optimistic that through time, we'll be able to bring down the risk of death”[11][12].
- Following the killing of George Floyd by Minneapolis police in May 2020, Bradway issued a statement noting that the incident “is part of a pattern that has become tragically clear in the U.S. and around the world. Equal justice and equal opportunity may be our ideals, but they are not yet our reality.” He declared the need to ensure that “all of our staff feel they belong at Amgen” and feel safe and welcome in our neighboring communities as well…The time is right and the moment is now for all of us at Amgen to do our part in setting a new standard…Let’s take inspiration from science and trust that progress, like knowledge, builds upon itself, incrementally improving on what exists today until the cumulative adds up to something profound. We are on a journey of a thousand miles,” Bradway concluded. “Let’s start taking some steps.”[13].
References
- ^ "AMGN-12.31.2012-10K". www.sec.gov.
- ^ "amgn-20201231". www.sec.gov. Retrieved 31 May 2022.
- ^ Mikulic, Matej. "Amgen R&D expenditure 2006-2021". Statista. Retrieved 31 May 2022.
- ^ "Amgen Buys deCODE Genetics for $415M". Genetic Engineering and Biotechnology News. Retrieved 31 May 2022.
- ^ Mukherjee. "Amgen acquires Onyx Pharmaceuticals for $10.4bn". Pharmaceutical Technology.
- ^ Taylor, Nick Paul (1 November 2019). "Amgen pays $2.7B to enlist BeiGene as Chinese R&D partner". Fierce Biotech. Retrieved 31 May 2022.
- ^ McDonald, Casey. "Biogen CEO Highlights Neuroscience Innovation Forum". PharmExec.
- ^ "LIVE 10:25 am – 12:00 pm 4/26/2016 Fireside Chat: Robert Bradway, CEO, Amgen & Immunotherapy I: Checkpoint Activation and Cancer Vaccines @2016 World Medical Innovation Forum: CANCER, April 25-27, 2016, Westin Hotel, Boston". Leaders in Pharmaceutical Business Intelligence (LPBI) Group. 26 April 2016. Retrieved 31 May 2022.
- ^ Schmitt, Jeff (24 April 2017). "Here's Who The Class Of 2017 Will Hear At Commencement". Poets&Quants.
- ^ Gurdus, Lizzy (7 January 2019). "Amgen CEO on cholesterol drug price cut: 'Too many patients' were struggling to pay". CNBC.
- ^ Pressman, Aaron (7 July 2020). "Amgen CEO is 'optimistic' about COVID-19 clinical trials". Fortune. Retrieved 31 May 2022.
- ^ Nusca, Andrew (10 July 2020). "What you missed at Fortune Brainstorm Health 2020". Fortune. Retrieved 31 May 2022.
- ^ Leuty, Ron (1 June 2020). "'Eyes can no longer be closed': CEOs speak as racial unrest spreads". San Francisco Business Times. Retrieved 31 May 2022.